Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DCAL | BSE
-1.30
-0.81%
Healthcare
Biotechnology
30/09/2023
08/12/2023
160.15
162.95
165.80
158.80
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs active pharmaceutical ingredients phase transfer catalysts quaternary ammonium compounds phosphoranes wittig reagents vitamin D products fine chemicals hand and body wash sanitizers antiseptics vitamin D analogues cholesterol lanolin-related products disinfectant formulations and various pharmaceutical and cosmetic-related products as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad India. As of March 30 2022 Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
View LessValue Stock (Price to Book < 3)
Price Below SMA10D
Smallcap (300M - 2B USD)
No Dividends (Dividend Yield = 0%)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
11.7%1 month
39.0%3 months
39.1%6 months
45.7%0
0
0.44
0.40
0.24
13.54
1.69
0
3.52B
25.11B
301.04M
0
-2.42
315.40
-4.50
-0.84
0
0
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
15.10
Range1M
35.70
Range3M
40.60
Rel. volume
0.65
Price X volume
5.28M